Hydryalix

Hydryalix is a line of cross-linked hyaluronic acid dermal fillers developed by Luminera for aesthetic soft tissue augmentation, including hydration, wrinkle correction, volumization, and contouring of the face. These products consist of sterile, non-animal origin, cross-linked hyaluronic acid gels, in some formulations combined with lidocaine to reduce injection pain, and are injected into various dermal or subdermal planes to correct fine lines, moderate to deep wrinkles, and to remodel facial contours such as lips, nasolabial folds, and midface volume. As temporary hyaluronic acid implants, Hydryalix fillers act by providing immediate volume and structural support in the extracellular matrix, with gradual biodegradation over time, and are marketed internationally as part of the Luminera dermal filler portfolio that was acquired by Allergan Aesthetics (AbbVie).[1][2][3][4][6][8]

Brand names

Hydryalix